Author - Maura D. Garvey

Helium swings from balance to surplus – but uncertainties remain.

In January 2023, the US captive on-purpose hydrogen production capacity stood at approximately 2.9 million cubic feet per day (mmcf/d). This describes hydrogen produced on-site for immediate use in an industrial context.

The 2024 merchant carbon dioxide (CO2) business will face the typical sourcing issues encountered every year – primarily, the normal plant turnarounds that start in March and carry into the summer, when ammonia plants are...

Plant builds remain neutral, with independent newcomers on the scene

Challenges of inflation on increasing healthcare costs

Helium tightness relaxes – return to supply-demand balance remains uncertain

The US hydrogen market – slow growth in the face of headwinds

The sourcing issues that continually affect the merchant carbon dioxide (CO2) business, and especially in the context of the federal government’s push toward carbon capture and sequestration (CCS) using tax credits, needs to be well-managed...

In the past year spending on healthcare, and on medical gases, has fallen, having climbed steeply as a response to tackling the Covid-19 crisis, writes Maura D. Garvey

There is clear evidence that plant builds are slowing, signaling a weakened economy